Narrowing the focus: Therapeutic cell surface targets for refractory triple-negative breast cancer

Triple-negative breast cancer (TNBC) is defined as a type of breast cancer with lack of expression of estrogen receptor, progesterone receptor and human epidermal growth factor 2 protein. In comparison to other types of breast cancer, TNBC characterizes for its aggressive behavior, more prone to ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Tafreshi, Narges K, Morse, David L, Lee, Marie Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186233/
https://www.ncbi.nlm.nih.gov/pubmed/32355639
http://dx.doi.org/10.5306/wjco.v11.i4.169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186233/
https://www.ncbi.nlm.nih.gov/pubmed/32355639
http://dx.doi.org/10.5306/wjco.v11.i4.169

Ejemplares similares